NEW YORK (GenomeWeb) – A study of a primary cervical cancer screening setting in Scotland has shown that patient-collected vaginal samples have comparable results to clinician-collected cervical samples when tested using Roche's cobas 4800 HPV assay.
Adoption of self-collected samples for cervical cancer screening via human papillomavirus testing must overcome hurdles of regulation and acceptance by clinicians. Comprehensive studies could influence the latter, chipping away at biases favoring clinician-collected samples.